Login
03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
- General Info
- Route
- ATC
- Indications
- Composition
- Excipients
- Side Effects
- Alternative Treatments
- Available In
-
May be acceptable
Use with caution
Contraindicated
| Apo-Esomeprazole 40mg : | |
| Type | Medicine Non Marketed |
| Originator | Nexium Tablets 40mg |
| Agent | Promopharm |
| Distributor | Promopharm |
| Laboratory | Apotex |
| Responsible Party | Apotex Inc |
| Origin | Canada |
| Manufacturer | Apotex Inc |
| Manufacturing Type | G |
| Origin | Canada |
| ATC | A02BC05 |
Apo-Esomeprazole 40mg :
Apo-Esomeprazole 40mg :
Apo-Esomeprazole 40mg :
Apo-Esomeprazole 40mg :
Apo-Esomeprazole 40mg :
| Hazard Level |
|---|
| ◼ Major |
| ◼ Moderate |
| ◼ Minor |
| ◼ Safe |
Apo-Esomeprazole 40mg :
| Frequency | Percentage |
|---|---|
| Very Common | ≥ 1/10 |
| Common | ≥ 1/100 - < 1/10 |
| Uncommon | ≥ 1/1,000 - < 1/100 |
| Rare | ≥ 1/10,000 - < 1/1,000 |
| Very Rare | < 1/10,000 |
| Unknown | Cannot be Estimated |
| Effect | Frequency |
|---|---|
| Abdominal pain | Common |
| Aggression | Very rare |
| Agitation | Rare |
| Agranulocytosis | Very rare |
| Alopecia | Rare |
| Anaphylactic reactions | Rare |
| Anaphylactic shock | Rare |
| Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
| Arthralgia (Pain joint) (Joint ache) | Rare |
| Bronchospasm | Rare |
| Confusional state | Rare |
| Constipation | Common |
| Depression | Rare |
| Dermatitis | Uncommon |
| Diarrhoea (Diarrhea) | Common |
| Dizziness | Uncommon |
| Dry mouth (Xerostomia) | Uncommon |
| Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Rare |
| Erythema multiforme | Very rare |
| Flatulence | Common |
| Gastrointestinal candidiasis | Rare |
| Gynecomastia (Gynaecomastia) | Very rare |
| Hallucination | Very rare |
| Headache | Common |
| Hepatic encephalopathy | Very rare |
| Hepatic enzyme increased | Uncommon |
| Hepatic failure (Hepatic insufficiency) (Liver failure) | Very rare |
| Hepatitis | Rare |
| Hyperhidrosis | Rare |
| Hypersensitivity | Rare |
| Hypocalcaemia | Not known |
| Hypokalaemia | Not known |
| Hypomagnesaemia | Not known |
| Hyponatraemia (Hyponatremia) | Rare |
| Insomnia | Uncommon |
| Jaundice | Not known |
| Leucopenia (Leukopenia) | Rare |
| Lyell Syndrome (Toxic epidermal necrolysis) | Very rare |
| Malaise | Rare |
| Microscopic colitis | Not known |
| Muscle weakness | Very rare |
| Myalgia | Rare |
| Nausea | Common |
| Oedema peripheral | Uncommon |
| Pancytopenia | Very rare |
| Paraesthesia (paresthesia) | Uncommon |
| Photosensitivity reaction | Rare |
| Pruritus | Uncommon |
| Pyrexia | Rare |
| Skin rash | Uncommon |
| Somnolence | Uncommon |
| Stevens-Johnson syndrome | Very rare |
| Stomatitis | Rare |
| Subacute cutaneous lupus erythematosus | Not known |
| Thrombocytopenia (Thrombopenia) | Rare |
| Tubulointerstitial nephritis | Very rare |
| Urticaria | Uncommon |
| Vertigo | Uncommon |
| Vision blurred | Rare |
| Vomiting | Common |
Apo-Esomeprazole 40mg :
| NB : Products With Same Indication |
Different Units By MoH Code
Apo-Esomeprazole 40mg MoH 6925 :
| Form | Tablet, Prolonged-release |
| Package Size | Box of 30 |
| Strength | 40mg |
| Storage Condition | 15-25°C Away from moisture |
| NSSF | ✘ |
| Quarantine | ✘ |
| Reg. Number | 96386/11 |
| Submission date | 01/01/2011 |
| Registration Year | 2013 |
| Archived Date | 03/05/2023 |
Price Comparison
| ● Country: | KSA | |
| ● Package Size: | 30 | |
| ● Public Price: | 65.6 SAR | ( 1,550,784.00 LBP ) |
| ● Pack size unit used: | 30 | |
| ● Cost/Unit: | 2,1867 SAR | ( 47,280.00 LBP ) |
| ● Reference: | sfda | |
| ● Pricing Date: | 16/01/2021 | |
| ● Type: | Medicine Authorised |
| ● Country: | Belgium | |
| ● Package Size: | 28 | |
| ● Public Price: | 12.07 EUR | ( 1,169,293.32 LBP ) |
| ● Pack size unit used: | 28 | |
| ● Cost/Unit: | 0,4311 EUR | ( 0.00 LBP ) |
| ● Reference: | cbip | |
| ● Pricing Date: | 27/11/2020 | |
| ● Type: | Medicine Authorised |
| ● Country: | Spain | |
| ● Package Size: | 28 | |
| ● Public Price: | 25.1 EUR | ( 2,431,587.60 LBP ) |
| ● Pack size unit used: | 28 | |
| ● Cost/Unit: | 0,8964 EUR | ( 0.00 LBP ) |
| ● Medica Comments: | Non Marketed | |
| ● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
| ● Pricing Date: | 06/05/2021 | |
| ● Type: | Medicine Non Marketed |
| ● Country: | Bahrain | |
| ● Package Size: | 30 | |
| ● Public Price: | 11.6 BHD | ( 2,757,714.40 LBP ) |
| ● Pack size unit used: | 30 | |
| ● Cost/Unit: | 0,3867 BHD | ( 0.00 LBP ) |
| ● Reference: | nhra | |
| ● Pricing Date: | 09/02/2021 | |
| ● Type: | Medicine Authorised |
| ● Country: | The Netherlands |
| ● Package Size: | 30 |
| ● Reference: | Zorginstituut Nederland |
| ● Pricing Date: | 15/06/2019 |
| ● Type: | Medicine Non Marketed |
- ◼ Lebanon
- ◼ Country of Origin
- ◼ Reference Countries
- ◼ Other Countries
You have to register to view this info
Upload File
Drop File
Uploading, Please wait ....
